Application of artificial intelligence technology in oncology: Towards the establishment of precision medicine R Hamamoto, K Suvarna, M Yamada, K Kobayashi, N Shinkai, M Miyake, ... Cancers 12 (12), 3532, 2020 | 148 | 2020 |
Prognostic impact of a ground-glass opacity component in clinical stage IA non–small cell lung cancer A Hattori, K Suzuki, K Takamochi, M Wakabayashi, K Aokage, H Saji, ... The Journal of Thoracic and Cardiovascular Surgery 161 (4), 1469-1480, 2021 | 112 | 2021 |
Predicting deep learning based multi-omics parallel integration survival subtypes in lung cancer using reverse phase protein array data S Takahashi, K Asada, K Takasawa, R Shimoyama, A Sakai, A Bolatkan, ... Biomolecules 10 (10), 1460, 2020 | 50 | 2020 |
Integrated analysis of whole genome and epigenome data using machine learning technology: toward the establishment of precision oncology K Asada, S Kaneko, K Takasawa, H Machino, S Takahashi, N Shinkai, ... Frontiers in oncology 11, 666937, 2021 | 32 | 2021 |
Application of artificial intelligence in COVID-19 diagnosis and therapeutics K Asada, M Komatsu, R Shimoyama, K Takasawa, N Shinkai, A Sakai, ... Journal of Personalized Medicine 11 (9), 886, 2021 | 25 | 2021 |
A multi-institutional randomized phase III trial comparing anatomical segmentectomy and wedge resection for clinical stage IA non-small cell lung cancer in high-risk operable … R Shimoyama, Y Tsutani, M Wakabayashi, H Katayama, H Fukuda, ... Japanese Journal of Clinical Oncology 50 (10), 1209-1213, 2020 | 15 | 2020 |
Prospective evaluation of watchful waiting for early-stage lung cancer with ground-glass opacity: a single-arm confirmatory multicenter study: Japan Clinical Oncology Group … T Miyoshi, K Aokage, M Wakabayashi, R Shimoyama, T Kataoka, ... Japanese Journal of Clinical Oncology 51 (8), 1330-1333, 2021 | 14 | 2021 |
A multi-institutional randomized phase III trial comparing postoperative radiotherapy to observation after adjuvant chemotherapy in patients with pathological N2 Stage III non … R Shimoyama, K Nakagawa, S Ishikura, M Wakabayashi, T Sasaki, ... Japanese journal of clinical oncology 51 (6), 999-1003, 2021 | 6 | 2021 |
Study protocol for a multi-institutional randomized phase III study comparing combined everolimus plus lanreotide therapy and everolimus monotherapy in patients with … R Shimoyama, S Hijioka, N Mizuno, G Ogawa, T Kataoka, H Katayama, ... Pancreatology 20 (6), 1183-1188, 2020 | 6 | 2020 |
A multi-institutional randomized phase III study comparing weekly carboplatin plus nab-paclitaxel and daily low-dose carboplatin as regimens for concurrent chemoradiotherapy in … R Shimoyama, S Omori, S Nomura, H Kenmotsu, T Takahashi, H Harada, ... Japanese Journal of Clinical Oncology 51 (5), 836-841, 2021 | 3 | 2021 |
5 か所の多発腸重積を来した皮膚悪性黒色腫小腸転移の 1 例 加藤伸弥, 西川和宏, 浜川卓也, 下山遼, 三宅正和, 濱直樹, 宮崎道彦, ... 日本消化器外科学会雑誌 54 (7), 490-496, 2021 | 1 | 2021 |
Recurrent Gastric Cancer with Tumor Bleeding from a Metastatic Lymph Node Invading the Duodenal Stump Successfully Controlled by Palliative Radiotherapy-A Case Report T Hamakawa, K Nishikawa, M Hirao, E Tanaka, T Iwasaki, R Shimoyama, ... Gan to Kagaku ryoho. Cancer & Chemotherapy 45 (13), 2366-2368, 2018 | 1 | 2018 |
Predicting Multi-Omics Parallel Integration Survival Subtypes in Lung Cancer Using Machine Learning Techniques S Takahashi, K Asada, K Takasawa, R Shimoyama, A Sakai, A Bolatkan, ... CANCER SCIENCE 113, 874-874, 2022 | | 2022 |
Clinical Trial Note R Shimoyama, Y Tsutani, M Wakabayashi, H Katayama, H Fukuda, ... Japanese Journal of Clinical Oncology 1, 6, 2020 | | 2020 |
Application of Artificial Intelligence Technology in Oncology: Towards the Establishment of Precision Medicine N Shinkai, M Miyake, M Takahashi, S Jinnai, R Shimoyama, A Sakai, ... | | |